Publications by authors named "Douglas Potter"

Claim this Profile
P
Protracted, Intermittent Outbreak of Salmonella Mbandaka Linked to a Restaurant - Michigan, 2008-2019.
William D Nettleton, Bethany Reimink, Katherine D Arends, Douglas Potter, Justin J Henderson

MMWR Morb Mortal Wkly Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior context influences motor brain areas in an auditory oddball task and prefrontal cortex multitasking modelling.
Carlos A Mugruza-Vassallo, Douglas D Potter, Stamatina Tsiora, Jennifer A Macfarlane, Adele Maxwell

Brain Inform· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eLIPS: Development and Validation of an Observational Tool for Examining Early Language in Play Settings.
Lynne G Duncan, Conny Gollek, Douglas D Potter

Front Psychol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of cognitive distraction on behavioural, oculomotor and electrophysiological metrics during a driving hazard perception task.
Steven W Savage, Douglas D Potter, Benjamin W Tatler

Accid Anal Prev· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context Dependence Signature, Stimulus Properties and Stimulus Probability as Predictors of ERP Amplitude Variability.
Carlos Mugruza-Vassallo, Douglas Potter

Front Hum Neurosci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of array structure and secondary cognitive task demand on processes of visual search.
Steven William Savage, Douglas D Potter, Benjamin W Tatler

Vision Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.
Hideho Okada, Lisa H Butterfield, Ronald L Hamilton, Aki Hoji, Masashi Sakaki, Douglas M Potter

Clin Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.
Ian F Pollack, Regina I Jakacki, Lisa H Butterfield, Ronald L Hamilton, Ashok Panigrahy, Douglas M Potter

J Clin Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma.
George Van Buren, Ramesh K Ramanathan, Alyssa M Krasinskas, Ryan P Smith, Gerard J Abood, Douglas M Potter

Ann Surg Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of withdrawal and intake of nicotine on smokers' ability to ignore distractors in a number parity decision task.
Stamatina Tsiora, Douglas D Potter, John S Kyle, Adele M Maxwell

Psychiatry J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.
Jacky T Yeung, Ronald L Hamilton, Koji Ohnishi, Maki Ikeura, Douglas M Potter

Clin Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.
Takashi Kimura, John R McKolanis, Lynda A Dzubinski, Kazi Islam, Douglas M Potter

Cancer Prev Res (Phila)· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal Gaze Cueing in Children with Autism Is Disrupted by Simultaneous Speech Utterances in "Live" Face-to-Face Interactions.
Douglas D Potter, Simon Webster

Autism Res Treat· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Benedito A Carneiro, Ramesh K Ramanathan, Marwan G Fakih, Smitha S Krishnamurthi, Barry C Lembersky, Douglas M Potter

Clin Colorectal Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.
Douglas M Potter, Lisa H Butterfield, Sherrie J Divito, Cindy A Sander, John M Kirkwood

J Immunol Methods· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex serum biomarker assessments: technical and biostatistical issues.
Lisa H Butterfield, Douglas M Potter, John M Kirkwood

J Transl Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.
Rajesh Sehgal, Barry C Lembersky, Kiran K Rajasenan, Theodore L Crandall, Edward P Balaban, Douglas M Potter

Clin Colorectal Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.
Lisa H Butterfield, A Karolina Palucka, Cedrik M Britten, Madhav V Dhodapkar, Leif Håkansson, Douglas M Potter

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
Hideho Okada, Pawel Kalinski, Ryo Ueda, Aki Hoji, Gary Kohanbash, Douglas M Potter

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychological consequence of soccer play in adolescent U.K. School team soccer players.
Richard Stephens, Andrew Rutherford, Douglas Potter, Gordon Fernie

J Neuropsychiatry Clin Neurosci· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fluorinated dendrimer-based nanotechnology platform: new contrast agents for high field imaging.
Zhihua Huang, Raghvendra S Sengar, Archana Nigam, Marie-Caline Abadjian, Douglas M Potter

Invest Radiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.
Renaud Warin, William H Chambers, Douglas M Potter, Shivendra V Singh

Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancer.
Ann Willman Silk, Robert E Schoen, Douglas M Potter, Olivera J Finn

Mol Immunol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma.
Philip Bao, Douglas Potter, David P Eisenberg, Diana Lenzner, Herbert J Zeh

HPB (Oxford)· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.
Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, Mitsugu Fujita, Xinmei Zhu, Douglas M Potter

Proc Natl Acad Sci U S A· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis